BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

计划入组 443 人 · 首次发布于 2023 年 4 月 18 日

PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron

计划入组 1 人 · 首次发布于 2002 年 5 月 27 日

SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)

计划入组 126 人 · 首次发布于 2018 年 6 月 12 日

Neuroregenerative agents(iNtRON Biotechnology, Inc.)

GN-200

Bacteriophage-based antibacterials(iNtRON Biotechnology, Inc.)

iNtRON Biotechnology, Inc.

South Korea

Puma Biotechnology

United States

MAIA Biotechnology

United States

iNtRON Seeks Partners to Repurpose SAL200 for MRSA Nasal Decolonization in Surgical Patients

iNtRON Bio Files Patent Applications for CRISPR-Cas9 Gene Editing Technology Targeting Pasteurella Bacteriophages

Puma Biotechnology Joins NASDAQ Biotechnology Index Following Commercial Success and Clinical Progress